Archive for Tag: Pfizer vaccine

PFIZER INC. WEEKLY TECHNICAL ANALYSIS – 14 MARCH 2022

PFIZER INC. Technical Analysis: Weekly Chart In the weekly charts, PFIZER INC. is trading in the up channel. It is trading below 20 days SMA & above 50 and 100 days SMA. The immediate support is 47.02 & the resistance level is at 51.87. PFIZER INC. is trading in...

Read More
Pfizer Inc

Pfizer vaccine for children under 5 may be available in U.S. by end-Feb

Pfizer Inc (NYSE: PFE) is trading down 3.02% at 52.69 Pfizer Inc (NYSE: PFE) and Germany’s BioNTech SE (NASDAQ: BNTX) are expected to submit an emergency use authorization request as early as Tuesday to the U.S. Food and Drug Administration (FDA) for vaccines for children aged six months to 5...

Read More

Pfizer files for U.S. authorization of promising COVID-19 antiviral pill

Pfizer Inc (NYSE:PFE) is trading down 0.10% at 49.60 Pfizer Inc (NYSE:PFE)said on Tuesday it is seeking U.S. authorization of its experimental antiviral COVID-19 pill that cut the chance of hospitalization or death for adults at risk of severe disease by 89% in a clinical trial. Pfizer said it...

Read More

Pfizer submits data for COVID-19 vaccine in younger children

Pfizer Inc is trading down 0.84% at 43.57 Pfizer Inc and BioNTech SE (NASDAQ:BNTX) on Tuesday submitted initial trial data for their COVID-19 vaccine in children aged 5 to 11 and said they would make a formal request with U.S. regulators for emergency use in the coming weeks. Coronavirus...

Read More

TOP 5 STOCKS TO WATCHOUT & TRADE TODAY – SEPTEMBER 23, 2021

1.VOLKSWAGEN: Software Volkswagen AG used to alter pollutant emissions based on the outside temperature and altitude is illegal and cannot be justified by its role in protecting the engine, an adviser to the EU’s top court said on Thursday. The finding, if confirmed by the Court of Justice of...

Read More

Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids

Pfizer Inc (NYSE:PFE) is trading down 1.30% at 43.89  Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) said on Monday their COVID-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to ask for authorization to use the vaccine in children in that age...

Read More

Pfizer on track for U.S. vaccine boosters, Moderna lagging, Fauci says

Pfizer (NYSE:PFE) is trading flat at 46.84 Top U.S. infectious disease expert Rd. Anthony Fauci said on Sunday that officials were likely to soon get the regulatory go-ahead to administer COVID-19 vaccine booster shots made byPfizer(NYSE:PFE), althoughModerna(NASDAQ:MRNA) booster could take a little longer. Asked on CBS’ “Face the Nation,”...

Read More

Pfizer seeks U.S. approval for COVID vaccine booster

Pfizer (NYSE:PFE)is trading up 0.24% at 47.50 Pfizer Inc on Wednesday said a booster dose of its two-shot COVID-19 vaccine spurs a more than threefold increase in antibodies against the coronavirus, as the company seeks U.S. regulatory approval for a third injection. The drugmaker and its German partner BioNTech...

Read More

Top 5 Stocks To Watchout & Trade Today – July 09, 2021

1. PFIZER:Pfizer Inc plans to ask U.S. regulators to authorize a booster dose of its COVID-19 vaccine within the next month, the drugmaker’s top scientist said on Thursday, based on evidence of greater risk of reinfection six months after inoculation and the spread of the highly contagious Delta variant....

Read More